交差点におけるトロゴサイトーシス:腫瘍と免疫細胞の相互作用の二元性を把握する
Xin Yang1, Xiaolu Huang2, Zhuonan Chen3
1Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University, Changsha, Hunan, China; Academician Workstation for Oral-maxillofacial and Regenerative Medicine, Central South University, Changsha, Hunan, China.
Biochimica et biophysica acta. Reviews on cancer
|August 27, 2025
まとめ
トロゴサイトーシスは 細胞の"噛む"プロセスで 逆説的に腫瘍免疫学に影響します このレビューでは,トロゴサイトーシスによる免疫細胞と腫瘍細胞の相互作用が,抗腫瘍免疫を高めるか,腫瘍免疫逃避を促進するかを調査しています.
科学分野:
- 免疫学
- 細胞生物学
- 癌 研究
背景:
- トロゴサイトーシスとは 細胞が膜の断片と分子を交換し 細胞の機能を変えることです
- 腫瘍免疫学におけるその役割は複雑で,その効果に関する証拠は矛盾しています.
研究 の 目的:
- 免疫細胞と腫瘍細胞の間の トロゴサイトーシスに関する最近の洞察をレビューする.
- 相互作用パターンを要約し,抗腫瘍免疫と腫瘍免疫回避における二重の役割を強調する.
- 癌の免疫療法におけるトロゴシトーシスの利用戦略を探求する.
主な方法:
- 腫瘍免疫学におけるトロゴサイトーシスに関する最近の研究の文献レビュー.
- 免疫細胞と腫瘍細胞の相互作用の分析
- トロゴシトーシスを標的とする治療戦略の探索
主要な成果:
- トロゴシトーシスは反逆的な効果を発揮し,抗腫瘍免疫 (トロゴプトーシス,抗原呈現) を強化したり,腫瘍の成長を促したりする可能性がある.
- 特定の免疫細胞には,T細胞,NK細胞,中性細胞,モノサイト/マクロファージ,CAR細胞,APCが含まれます.
- 異なる相互作用パターンは,がん免疫における有益な結果と有害な結果の両方に寄与する.
結論:
- トロゴサイトーシスは腫瘍免疫学において重要な二重の役割を果たし,抗腫瘍反応と腫瘍免疫脱出の両方に影響を与えます.
- これらの複雑な相互作用を理解することは 新種のがん免疫療法の開発の鍵です
- トロゴシトーシスをターゲットにすることで がん治療の治療成果を向上させる見込みのある戦略が生まれます
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
Cell-mediated Immune Responses
72.2K
Overview
72.2K
Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K


